MDLN 10-Q Quarterly Reports
Medline Inc. - 2 quarterly reports
Medline Inc. Quarterly Report for Q2 Ended Jun 27, 2026
Aug 5, 2026Medline Inc. (MDLN) reported its second-quarter 2026 financial results, demonstrating robust top-line growth alongside significant operational events and strategic financial activities. The company saw a notable increase in net sales, driven by higher volumes across both its Medline Brand and Supply Chain Solutions segments. This growth was partially impacted by customer repayments related to tariff refunds, which reduced reported net sales. Operationally, Medline faced a significant challenge with a fire at its Tracy, California distribution center, resulting in an estimated $336 million loss. The company has initiated insurance discussions and secured new lease agreements to mitigate disruptions. Financially, Medline executed several debt refinancing transactions in May 2026, leading to lower interest expenses. The company also reported a substantial increase in its Tax Receivable Agreement (TRA) liability, primarily due to secondary offerings and unit exchanges. Investors should note the strong sales performance, the ongoing efforts to manage the impact of the distribution center fire, and the significant debt restructuring. The increase in the TRA liability is a key financial item to monitor, reflecting expected future tax benefits. Despite operational challenges, the company's liquidity remains strong, supported by cash reserves and its revolving credit facility.
Medline Inc. Quarterly Report for Q1 Ended Mar 28, 2026
May 6, 2026Medline Inc. reported solid revenue growth of 10.7% for the quarter ended March 28, 2026, reaching $7.35 billion, driven primarily by increased volumes across its U.S. operations, particularly within the acute care segment. Despite this top-line expansion, net income saw a decline of 25.8% to $239 million, largely due to a significant increase in Cost of Goods Sold (up 14.3%) and Selling, General, and Administrative (SG&A) expenses (up 14.8%). Higher import costs related to tariffs and increased compensation and distribution expenses were key drivers for the rise in operating costs. The company also experienced a substantial decrease in interest expense, down 35.2% to $136 million, following the repayment of significant debt portions using IPO proceeds in the prior year, which positively impacted profitability. The balance sheet remains strong with $2.24 billion in cash and cash equivalents and $946 million in available liquidity under its revolving credit facility. The company continues to manage its financial obligations, with a total indebtedness of $12.76 billion as of the quarter's end.